Europe Cold Sore Treatment (for HSV 1 Virus) Market

Europe Cold Sore Treatment (for HSV 1 Virus) Market

Europe cold sore treatment (for HSV 1 virus) market is expected to reach USD 325.19 million by 2031, from USD 207.15 million in 2023, growing at the CAGR of 6.2% in the forecast period of 2024 to 2031.
Market Segmentation
Europe Cold Sore Treatment (for HSV 1 Virus) Market, By Treatment Type (Medications, Applied Products, Cold Sore Patches, and Others(Non Medicated Products)), Route Of Administration (Oral, Topical, and Others), Mode Of Purchase (Over The Counter and Prescription Drug), Strain Type (Herpes Simplex Type 1 Virus and Herpes Simplex Type 2 Virus), Drug Type (Generic and Branded), Population Type (Adults, Pediatrics, and Geriatrics), Gender (Female and Male), End User (Home Healthcare, Hospitals, Specialty Clinics, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Others), By Country (U.K., Germany, France, Spain, Italy, Belgium, Russia, Switzerland, Netherlands, Turkey, and rest of Europe) – Industry Trends and Forecast to 2031
Overview of Europe Cold Sore Treatment (for HSV 1 Virus) Market Dynamics
Drivers
• Growing prevalence of cold sore infection
• Growing awareness about cold sore symptoms and treatment options
• Impact of generic drugs on the global cold sore treatment (for HSV 1 virus) market
Restraints
• Development of drug-resistant strains of HSV-1 and H11 viruses
• Lack of curative treatment for infection
Opportunities
• Rising advancements in treatments for cold sore infections
• Increasing adoption of telemedicine and digital health solutions
Challenges
• Increasing complexity of vaccine development
• Side effects associated with medications in treating cold sore
Market Players
The key market players for Europe cold sore treatment (for HSV 1 virus) market are listed below:
• Fresenius SE & Co. KGaA
• Zydus Pharmaceuticals, Inc.
• Teva Pharmaceuticals Industries Ltd.
• Novartis AG
• Sun Pharmaceutical Industries Ltd.
• Quantum Health
• GSK plc.
• Haleon Group of Companies
• Church & Dwight Co., Inc.
• Hikma Pharmaceuticals PLC
• Viatris Inc.
• Carma Labs Inc.
• URGO MEDICAL
• Apotex Inc.
• Amneal Pharmaceuticals LLC
• Blistex Inc.
• FOCUS CONSUMER HEALTHCARE
• Hetero Healthcare Limited
• Amparo medical Technologies
• Devirex AG


Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.